Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 68236X100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Sarin Ravi Yang
13D/A
|
4.7% |
4/23/2025
Event 3/26/2025
|
||
| Ravi Sarin | 4.7% | |||
| OncologyCare Partners, LLC | 4.7% | |||
|
FMR LLC
13G/A
|
0% |
12/6/2024
Event 11/29/2024
|
||
| FMR LLC | 0% | |||
| Abigail P. Johnson | 0% | |||
|
FOG Ventures Investments, LLC
13G/A
|
0% |
6/24/2025
Event 5/15/2025
|
||
| FOG Ventures Investments, LLC | 0% | |||
| Daniel Murillo | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 8 | 112 k | $695 k |
| 2026 Q2 | 127 | 40.1 M | $219 M |
| 2026 Q1 | 121 | 38.8 M | $119 M |
| 2025 Q4 | 126 | 38.5 M | $137 M |
| 2025 Q3 | 116 | 34.7 M | $121 M |
| 2025 Q2 | 82 | 32.3 M | $66.1 M |
| 2025 Q1 | 44 | 17.1 M | $19.4 M |
| 2024 Q4 | 32 | 14.7 M | $4.61 M |
| 2024 Q3 | 36 | 20.6 M | $6.98 M |
| 2024 Q2 | 43 | 18.7 M | $8.85 M |
| 2024 Q1 | 51 | 17.4 M | $28.4 M |
| 2023 Q4 | 49 | 18.5 M | $38.3 M |
| 2023 Q3 | 38 | 15.1 M | $21.2 M |
| 2023 Q2 | 40 | 13.9 M | $7.66 M |
| 2023 Q1 | 40 | 22.0 M | $15.3 M |
| 2022 Q4 | 42 | 23.9 M | $39.9 M |
| 2022 Q3 | 41 | 23.4 M | $108 M |
| 2022 Q2 | 37 | 21.9 M | $111 M |
| 2022 Q1 | 31 | 21.1 M | $159 M |
| 2021 Q4 | 22 | 21.1 M | $200 M |
| 2021 Q3 | 1 | 252 k | $2.50 M |